In this study, our results showed that ILK gene-modified BMSCs significantly increased SDF-1, bFGF, and VEGF-A expression levels and decreased the CDH1 expression level compared with BMSC treatment, subsequently promoted the vascular remodeling in hyperglycemia-induced ischemia of the bladder tissue. The gene discussed is CXCL12; the disease is ischemia.